C07K 14/77
Ovalbumin
C07K14/77 (Ovalbumin) appears on 111 US grants and 160 published applications in this corpus.
Search patents in C07K- Granted patents
- 111
- Published applications
- 160
- Assignees
- 118
- Inventors
- 375
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 9 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 3 | 5 |
| 2003 | 2 | 6 |
| 2004 | 1 | 2 |
| 2005 | 1 | 1 |
| 2006 | 3 | 7 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 2 | 6 |
| 2010 | 0 | 4 |
| 2011 | 3 | 0 |
| 2012 | 3 | 7 |
| 2013 | 4 | 7 |
| 2014 | 2 | 7 |
| 2015 | 7 | 13 |
| 2016 | 5 | 8 |
| 2017 | 8 | 7 |
| 2018 | 3 | 5 |
| 2019 | 5 | 5 |
| 2020 | 2 | 4 |
| 2021 | 3 | 5 |
| 2022 | 5 | 10 |
| 2023 | 5 | 16 |
| 2024 | 9 | 11 |
| 2025 | 5 | 7 |
| 2026 | 0 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Extracellular vesicles for vaccine delivery23 Dec 2025US 12,502,427 B2Lonza Sales AG
- Phage-derived particles for in situ delivery of DNA payload into C. acnes population4 Nov 2025US 12,460,216 B2Eligo Bioscience
- Cutibacterium acnes recombinant phages encoding a human protein28 Oct 2025US 12,454,696 B2Eligo Bioscience
- Exosome-targeted DNA vaccine3 Jun 2025US 12,319,727 B2Exorphia, Inc.
- Exosome-targeted DNA vaccine28 Jan 2025US 12,209,115 B2Exorphia, Inc.
- Nicotinamide adenine dinucleotide devices and compositions and methods for making the same27 Aug 2026US 2026/0250695 A1Bio Capital Holdings, LLC
- Expression of modified proteins in a peroxisome13 Aug 2026US 2026/0234647 A1The Regents of the University of California
- Cutibacterium acnes recombinant phages, method of production and uses thereof6 Aug 2026US 2026/0226484 A1Eligo Bioscience
- Protein devices and compositions and methods for making the same30 Jul 2026US 2026/0218214 A1Bio Capital Holdings, LLC
- Glycotargeting therapeutics30 Apr 2026US 2026/0115300 A1Ecole Polytechnique Federale De Lausanne (Epfl)
Most cited
By later US patents
- Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides190US 5,679,647 AThe Regents of the University of California · 1997
- Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin129US 5,529,915 ASterling Winthrop Inc. · 1996
- Method for treating allergic lung disease110US 5,849,719 AThe Regents of the University of California · 1998
- Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides89US 5,804,566 AThe Regents of the University of California · 1998
- Product and process for targeting an immune response80US 5,698,679 ANational Jewish Center for Immunology and Respiratory Medicine · 1997